Streetbeat News

Partnerships

CBAT

CBAK Energy Technology's subsidiary, Nanjing CBAK New Energy Technology, has signed a strategic agreement with Guangzhou Echom Science & Technology. Echom will purchase about ¥180 million worth of CBAK Energy's cylindrical lithium-ion batteries over the next three years. Echom is also obligated to prioritize CBAK Energy's batteries in its new energy storage products and ensure that over 50% of its relevant products utilize CBAK Energy's batteries.

Portfolio Pulse from Shivani Kumaresan

July 10, 2023 | 1:47 pm

SPY

VGK

The European Union has sealed a new transatlantic data transfers pact with the United States, according to Reuters. This agreement is expected to ensure that companies can continue to transfer personal data across the Atlantic, a process that is crucial for many businesses.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:44 pm

DIS

EA

Cliffhanger Games, a new EA studio, has announced an upcoming title based on Marvel's Black Panther. The game is being developed in collaboration with Marvel Games and is led by Kevin Stephens, a veteran from Monolith Productions. The team includes leaders from acclaimed franchises such as Halo Infinite, God of War, and Call of Duty. The game aims to provide an authentic Black Panther experience and allow players to explore the world of Wakanda.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:40 pm

AAPL

INDA

Foxconn, a major supplier for Apple, has withdrawn from a $19.5 billion joint venture in India that was set to produce semiconductor and display components. The reason for the withdrawal was not provided. This move is a significant setback to India's ambitions to become a global high-tech manufacturing hub. Despite this, Foxconn continues to build other factories across India.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:36 pm

ALPP

Alpine 4 Holdings Inc's shares are trading higher after its subsidiary, Vayu Aerospace Corporation, received a $5.25 million purchase order from All American Contracting. This is the first order from a $100 million supply agreement. The company's CEO, Kent Wilson, expressed optimism about the potential for significant revenue generation.

Portfolio Pulse from Adam Eckert

July 10, 2023 | 1:31 pm

ALPP

Alpine 4's subsidiary, Vayu Aerospace, has received its first $5.25 million purchase order from its $100 million supply agreement with All American Contracting, a U.S. government contractor. This has led to a rise in Alpine 4's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 1:30 pm

NVEI

Canadian fintech company Nuvei Corporation (NASDAQ:NVEI) has been selected by mobility solutions provider inDrive as its payments provider for payouts to its drivers in Latin America. Nuvei will enable inDrive to offer a comprehensive range of payout options, including payments to cards and alternative payment methods (APMs) in the region. This partnership is significant for the Latin American market, which faces unique payment challenges including lower card acceptance rates and a significant unbanked population.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:15 pm

ALBT

Avalon GloboCare Corp. (NASDAQ:ALBT) has updated its commercial strategy, focusing on acquiring and operating revenue-generating laboratories and commercialized products. The company has acquired a 40% interest in Laboratory Services MSO, LLC (LSM), which generated $14.7 million in revenue and $6.3 million in net income in 2022. Avalon also secured exclusive distribution rights for the KetoAir™ breathalyzer device in North America, South America, the U.K., and the European Union. The company is also working on joint patent filings with the Massachusetts Institute of Technology (MIT).

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:13 pm

ACST

Acasti Pharma has announced that WuXi Clinical will conduct the STRIVE-ON Phase 3 safety trial for GTX-104 in aSAH patients. The trial aims to evaluate the safety and tolerability of GTX-104 compared to oral nimodipine.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 1:08 pm

JNJ

NBTX

Nanobiotix S.A. (NASDAQ:NBTX) has entered into a license agreement with Janssen Pharmaceutical, a subsidiary of Johnson & Johnson (NYSE:JNJ), for the global co-development and commercialization of NBTXR3. Nanobiotix will receive cash and operational support valued at up to $60 million, including a licensing fee of $30 million. The company is also eligible for success-based payments of up to $1.8 billion and will receive royalties following commercialization.

Portfolio Pulse from Adam Eckert

July 10, 2023 | 1:00 pm